I. Richard Thompson
- Cancer Research top 2%
- Molecular Biology top 5%
- RNA modifications and cancer 4
- RNA Research and Splicing 3
- Pluripotent Stem Cells Research 2
- Epigenetics and DNA Methylation 2
- Oncology top 5%
-
- Genetics and Neurodevelopmental Disorders 4
- Genomic variations and chromosomal abnormalities 3
- Genomics and Rare Diseases 2
-
- Autism Spectrum Disorder Research 4
- Co-authors
- Patricia GreningerSimon ForbesCyril H. BenesP. Andrew FutrealDaniel A. HaberHoward LightfootMichael R. StrattonWanjuan Yang
- Partner nations
- QatarUnited KingdomUnited States
In The Last Decade
I. Richard Thompson
23 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 886
- Computational Theory and Mathematics 494
- Molecular Biology 1.9k
- Pulmonary and Respiratory Medicine 899
- Oncology 675
Countries citing papers authored by I. Richard Thompson
This map shows the geographic impact of I. Richard Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Richard Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Richard Thompson more than expected).
Fields of papers citing papers by I. Richard Thompson
This network shows the impact of papers produced by I. Richard Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Richard Thompson. The network helps show where I. Richard Thompson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside I. Richard Thompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 5 | |
| 13 | 2020 | 11 | |
| 14 | 2019 | 21 | |
| 15 | 2018 | 10 | |
| 16 | 2017 | 22 | |
| 17 | 2016 | 19 | |
| 18 | Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsbreakdown → | 2012 | 2597 |
| 19 | 2009 | 0 | |
| 20 | 2009 | 6 |
About I. Richard Thompson
I. Richard Thompson is a scholar working on Equine, Periodontics and Biological Psychiatry, having authored 24 papers that have together received 2.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Genetics and Neurodevelopmental Disorders (4 papers), Autism Spectrum Disorder Research (4 papers), Genomic variations and chromosomal abnormalities (3 papers), RNA Research and Splicing (3 papers), Genomics and Rare Diseases (2 papers), Pluripotent Stem Cells Research (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (886 citations), Computational Theory and Mathematics (494 citations) and Molecular Biology (1.9k citations). I. Richard Thompson has collaborated with scholars based in Qatar, United Kingdom and United States. Frequent co-authors include Patricia Greninger, Simon Forbes, Cyril H. Benes, P. Andrew Futreal, Daniel A. Haber, Howard Lightfoot, Michael R. Stratton, Wanjuan Yang, Sridhar Ramaswamy and Ultan McDermott. Their work appears in journals such as Nucleic Acids Research, Bioinformatics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.